East Lyme, CT, United States of America

Pamela K Klose

This inventor holds 2 USPTO granted patents. Top assignees: Pfizer Corporation, Zoetis LLC. Active years: 2006-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Pamela K Klose. Retrieved from https://idiyas.com/inventor/pamela-k-klose

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 47(Granted Patents)


Company Filing History:


Years Active: 2006-2014

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Pamela K Klose

Introduction

Pamela K Klose is a notable inventor based in East Lyme, CT (US). She has made significant contributions to the field of vaccine development, holding 2 patents that focus on enhancing immunogenicity through innovative emulsions.

Latest Patents

Her latest patents include the development of microfluidized oil-in-water emulsions and vaccine compositions. This invention provides submicron oil-in-water emulsions that serve as a vaccine adjuvant, enhancing the immunogenicity of antigens. The present invention also includes vaccine compositions that combine an antigen with such emulsions, either intrinsically or extrinsically. Additionally, methods for preparing these emulsions and vaccines are outlined in her patents.

Career Highlights

Throughout her career, Pamela has worked with prominent companies such as Pfizer Corporation and Zoetis LLC. Her experience in these organizations has contributed to her expertise in vaccine technology and formulation.

Collaborations

Pamela has collaborated with notable professionals in her field, including Paul Joseph Dominowski and Richard Lee Krebs. These collaborations have further enriched her work and innovations in vaccine development.

Conclusion

Pamela K Klose's contributions to vaccine technology through her innovative patents highlight her role as a significant figure in the field. Her work continues to impact the development of effective vaccine formulations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…